These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
530 related articles for article (PubMed ID: 33841132)
1. Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy. Hofschröer V; Najder K; Rugi M; Bouazzi R; Cozzolino M; Arcangeli A; Panyi G; Schwab A Front Pharmacol; 2020; 11():586599. PubMed ID: 33841132 [TBL] [Abstract][Full Text] [Related]
2. Ion channels in control of pancreatic stellate cell migration. Storck H; Hild B; Schimmelpfennig S; Sargin S; Nielsen N; Zaccagnino A; Budde T; Novak I; Kalthoff H; Schwab A Oncotarget; 2017 Jan; 8(1):769-784. PubMed ID: 27903970 [TBL] [Abstract][Full Text] [Related]
3. Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma. Schnipper J; Dhennin-Duthille I; Ahidouch A; Ouadid-Ahidouch H Front Pharmacol; 2020; 11():568993. PubMed ID: 33178018 [TBL] [Abstract][Full Text] [Related]
4. Role of TRPC1 channels in pressure-mediated activation of murine pancreatic stellate cells. Fels B; Nielsen N; Schwab A Eur Biophys J; 2016 Oct; 45(7):657-670. PubMed ID: 27670661 [TBL] [Abstract][Full Text] [Related]
5. The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives. Wu Y; Zhang C; Jiang K; Werner J; Bazhin AV; D'Haese JG Front Oncol; 2020; 10():621937. PubMed ID: 33520728 [TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment. Tarannum M; Vivero-Escoto JL Adv Drug Deliv Rev; 2022 Aug; 187():114357. PubMed ID: 35605679 [TBL] [Abstract][Full Text] [Related]
7. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma. Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602 [TBL] [Abstract][Full Text] [Related]
8. Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours. Huang HC; Sung YC; Li CP; Wan D; Chao PH; Tseng YT; Liao BW; Cheng HT; Hsu FF; Huang CC; Chen YT; Liao YH; Hsieh HT; Shih YC; Liu IJ; Wu HC; Lu TT; Wang J; Chen Y Gut; 2022 Sep; 71(9):1843-1855. PubMed ID: 34921062 [TBL] [Abstract][Full Text] [Related]
9. Disrupting the balance between tumor epithelia and stroma is a possible therapeutic approach for pancreatic cancer. Wang Z; Li J; Chen X; Duan W; Ma Q; Li X Med Sci Monit; 2014 Oct; 20():2002-6. PubMed ID: 25327552 [TBL] [Abstract][Full Text] [Related]